HomeLSL • CVE
add
LSL Pharma Group Inc
Previous close
$0.38
Day range
$0.37 - $0.37
Year range
$0.29 - $0.53
Market cap
44.26M CAD
Avg Volume
58.43K
P/E ratio
12.05
Dividend yield
-
Primary exchange
CVE
Market news
Yahoo Finance
10 hours ago
This Fintech Stock Dropped 40% Today to Lead S&P 500 Decliners. Here's Why.
44.04%
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 7.22M | 72.23% |
Operating expense | 1.76M | 4.71% |
Net income | -389.00K | 24.61% |
Net profit margin | -5.39 | 56.21% |
Earnings per share | — | — |
EBITDA | 1.01M | 395.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.97M | 1,619.38% |
Total assets | 61.80M | 67.25% |
Total liabilities | 37.40M | 113.96% |
Total equity | 24.40M | — |
Shares outstanding | 115.53M | — |
Price to book | 1.79 | — |
Return on assets | — | — |
Return on capital | 1.53% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -389.00K | 24.61% |
Cash from operations | 1.49M | 1,489.72% |
Cash from investing | -985.00K | 69.57% |
Cash from financing | 4.29M | 17.02% |
Net change in cash | 4.79M | 1,388.20% |
Free cash flow | — | — |
About
Founded
2010
Website
Employees
185
